Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein
- 1 July 1985
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 49 (1), 172-181
- https://doi.org/10.1128/iai.49.1.172-181.1985
Abstract
Immune regulation in candidiasis is inferred from studies of both human and animal infection with a suppressive role suggested for cell wall polysaccharide. To study the immunosuppressive potential of Candida albicans in a murine model, whole blastoconidia or purified cell wall components of C. albicans were tested for their effects on the devlopement of acquired immune responses by superimposing a pretreatment regimen upon an established immunization protocol. CBA/J or BALB/cByJ mice were pretreated twice intravenously with 100 .mu.g of mannan (MAN), 100 or 200 .mu.g of glycoprotein (GP), or 5 .times. 107 heat-killed C. albicans blastoconidia, followed 1 week later by an immunization protocol of two cutaneous inoculations of viable C. albicans blastoconidia given 2 weeks apart. Delayed hypersensitivity (DTH) to GP or to a membrane-derived antigen, B-HEX, was tested 7 days after the second inoculation, and lymphocyte stimulation was tested with mitogens and Candida antigens after 12 days. To assess protection, mice were challenged intravenously with viable C. albicans blastoconidia 14 days after the second cutaneous inoculation and sacrificed 28 days later for quantitative culture of kidneys and brains. Sera were obtained for enzyme-linked immunosorbent assays at selected intervals. Pretreatment with GP resulted in specific in vivo suppression of DTH to GP but not to B-HEX antigen and specific in vitro suppression of lymphocyte stimulation to GP but not to other Candida antigens or mitogens. MAN and heat-killed C. albicans blastoconidia had no such effects. GP pretreatment also diminished the protective effect of immunization against challenge, demonstrable in the brain, while not altering significantly the production of antibody in response to infection. Contrary to clinical evidence, MAN was not immunosuppressive in this model, and in fact, the immunosuppressive potential of GP, which is composed largely of MAN, was found to be dependent upon the presence of its heat-labile protein moiety.This publication has 43 references indexed in Scilit:
- Immunodeficient CBA/N mice respond effectively to Candida albicansClinical Immunology and Immunopathology, 1984
- Role of Histamine in the Regulation of Cell-Mediated ImmunityInternational Archives of Allergy and Immunology, 1981
- The regulatory effect of histamine on the immune response: Characterization of the cells involvedCellular Immunology, 1980
- Suppressive action of cytoplasmic and metabolite extracts of Candida albicans on the immune response in guinea pigsMycopathologia, 1980
- Hemodynamic effects of the glycoprotein isolated from cell wall of Candida albicansToxicon, 1979
- The effect of polysaccharide-protein complex isolated fromCandida albicans on regional blood flow in ratsCellular and Molecular Life Sciences, 1979
- Suppressive Action of Candida albicans on the Immune Response in MicePathobiology, 1979
- Suppression of lymphocyte blastogenesis by Candida albicansClinical Immunology and Immunopathology, 1978
- Suppressor thymus-derived lymphocytes in fungal infection.Journal of Clinical Investigation, 1976
- Immunotherapy of CoccidioidomycosisJournal of Clinical Investigation, 1974